Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-68ccn Total loading time: 0 Render date: 2024-07-09T06:20:39.901Z Has data issue: false hasContentIssue false

5 - Recombinant and Synthetic Vaccines

Published online by Cambridge University Press:  05 June 2012

Alexander N. Glazer
Affiliation:
University of California, Berkeley
Hiroshi Nikaido
Affiliation:
University of California, Berkeley
Get access

Summary

In developing countries, infectious diseases still cause 30% to 50% of all deaths. Effective chemotherapeutic agents simply do not exist for many of the diseases that plague these regions, and many of the agents that do exist are far too costly for much of the population to afford. Vaccines thus have become the most important tool for fighting infectious diseases in those parts of the world.

The situation is very different in developed countries, where infectious diseases account for only 4% to 8% of all deaths. This is not to say, however, that vaccines are not important in those parts of the world. The low rate of infectious diseases in industrialized nations is in fact largely the result of the widespread use of vaccination (Figure 5.1). In addition to the well-known example of the smallpox vaccine, which has succeeded in eradicating the disease completely, other vaccines have brought dramatic decreases in the incidence of numerous grave diseases. For example, at the beginning of the twentieth century, diphtheria (caused by the bacterium Corynebacterium diphtheriae) infected about 3000 children yearly out of every million in developed countries. Because diphtheria targets young children in particular, this incidence corresponds to several percent of children of the susceptible age, and nearly one tenth of the infected children died. Now, thanks to a mass immunization program, diphtheria incidence in the United States is less than 0.2 per million, a decrease of more than a thousandfold.

Type
Chapter
Information
Microbial Biotechnology
Fundamentals of Applied Microbiology
, pp. 169 - 202
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×